American Cancer Society updates prostate cancer screening guidelines
Solo los hechos

American Cancer Society updates prostate cancer screening guidelines

Resumen

The Society now advises men at average risk to begin PSA testing every two years at age 50, with earlier and more frequent screening for Black men and those with a family history.

The American Cancer Society released updated prostate cancer screening guidelines on Nov. 12, recommending that men at average risk start PSA testing every two years at age 50 and continue through age 69. The guidance advises Black men to begin annual screening at age 45, regardless of family history, and men with a father, brother or son diagnosed with prostate cancer to also start at 45, with screening frequency based on their family history. Men aged 70 to 74 should discuss continuation of screening with their physicians, while routine testing is not recommended for those 75 and older.

Prostate cancer remains the second-leading cause of cancer death among U.S. men, but the five-year relative survival rate for disease confined to the prostate is nearly 100%, according to the Society. A PSA level of 3 ng/mL or higher in men under 70 triggers a repeat test, though elevated PSA can also result from benign conditions such as an enlarged prostate, inflammation or infection.

Dr. Ash Tewari, chair of the Milton and Carroll Petrie Department of Urology at Icahn School of Medicine at Mount Sinai, emphasized the importance of screening, noting that treatment success rates are high but many men still need encouragement to be tested. He highlighted the Society’s recommendation that low-risk cancers be managed with active surveillance rather than immediate treatment.

To increase access, Mount Sinai operates a mobile prostate cancer screening unit that travels to community locations, including a recent deployment at a football game in Atlanta in partnership with the Winship Cancer Institute at Emory University. The initiative aims to screen more than one million men as part of the “Million Strong Men” campaign.

The Society estimates that more than 333,000 U.S. men will be diagnosed with prostate cancer in 2026 and about 36,000 will die from the disease.

Fuente

Fox News

Sigue leyendo, gratis

Crea una cuenta gratis para seguir las noticias. No se requiere tarjeta.